Recursion Pharmaceuticals

OverviewSuggest Edit

Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology. The company uses high-throughput genetic manipulation to model many diseases in multiple human cell types. 
TypePrivate
Founded2013
HQSalt Lake City, US
Websiterecursionpharma.com
Employee Ratings4.6
Overall CultureA+

Latest Updates

Employees (est.) (Nov 2020)176(+3%)
Cybersecurity ratingAMore

Key People/Management at Recursion Pharmaceuticals

Zachary Bogue

Zachary Bogue

Board Member
Kevin Brown

Kevin Brown

Vice President, Intellectual Property
Joseph Carpenter

Joseph Carpenter

Director of Chemistry
Brooke Clark

Brooke Clark

Senior Director of Talent Acquisition
Zavain Dar

Zavain Dar

Board Member
Joel Ellis

Joel Ellis

Director of Toxicology
Show more

Recursion Pharmaceuticals Office Locations

Recursion Pharmaceuticals has an office in Salt Lake City
Salt Lake City, US (HQ)
41 S Rio Grande St
Show all (1)

Recursion Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2013

Recursion Pharmaceuticals total Funding

$437.1 m

Recursion Pharmaceuticals latest funding size

$239 m

Time since last funding

3 months ago

Recursion Pharmaceuticals investors

Recursion Pharmaceuticals's latest funding round in September 2020 was reported to be $239 m. In total, Recursion Pharmaceuticals has raised $437.1 m
Show all financial metrics

Recursion Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Recursion Pharmaceuticals Online and Social Media Presence

Embed Graph

Recursion Pharmaceuticals Company Culture

  • Overall Culture

    A+

    90/100

  • CEO Rating

    A+

    93/100

  • Compensation

    A+

    89/100

Learn more on Comparably

Recursion Pharmaceuticals News and Updates

Recursion Pharmaceuticals amasses $121 mln Series C

Salt Lake City-based Recursion Pharmaceuticals, a next-gen biopharma company, has secured $121 million in Series C financing. Baillie Gifford’s flagship investment trust Scottish Mortgage Investment Trust PLC led the round.

Biotech company Recursion Pharmaceuticals fetches $60 mln Series B

Salt Lake City-based Recursion Pharmaceuticals, a biotechnology company, has secured $60 million in Series B financing. Data Collective led the round.

Recursion Pharmaceuticals Blogs

Building a Start-up Ecosystem for Utah Biotech Entrepreneurs

The post Building a Start-up Ecosystem for Utah Biotech Entrepreneurs appeared first on Recursion Pharmaceuticals.

Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2

The post Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2 appeared first on Recursion Pharmaceuticals.

Recursion Pharmaceuticals Frequently Asked Questions

  • When was Recursion Pharmaceuticals founded?

    Recursion Pharmaceuticals was founded in 2013.

  • Who are Recursion Pharmaceuticals key executives?

    Recursion Pharmaceuticals's key executives are Zachary Bogue, Kevin Brown and Joseph Carpenter.

  • How many employees does Recursion Pharmaceuticals have?

    Recursion Pharmaceuticals has 176 employees.

  • Who are Recursion Pharmaceuticals competitors?

    Competitors of Recursion Pharmaceuticals include BenevolentAI, Reborna Biosciences and Sarepta Therapeutics.

  • Where is Recursion Pharmaceuticals headquarters?

    Recursion Pharmaceuticals headquarters is located at 41 S Rio Grande St, Salt Lake City.

  • Where are Recursion Pharmaceuticals offices?

    Recursion Pharmaceuticals has an office in Salt Lake City.

  • How many offices does Recursion Pharmaceuticals have?

    Recursion Pharmaceuticals has 1 office.